The 13thth World Stem Cell Summit www.worldstemcellsummit.com is taking place January 23-26, 2018 at the Hyatt Regency Miami. Produced by the nonprofit Regenerative Medicine Foundation (RMF), the event is the global ecosystem meeting for advanced therapies; fostering public understanding, promoting positive policy initiatives and collaborations.
|
|||
The World Stem Cell Summit will be co-located with the field’s premier industry partnering event, Phacilitate Leaders Forum, Cell & Gene Therapy World and Immunotherapy World.
In addition to compelling keynotes, plenary and focus sessions, the diverse four-day program includes expert lunch roundtables; a centrally located Expo packed with innovators in industry, academia and government; a poster forum showcasing science and policy research; the gala Stem Cell Action Awards Dinner http://regmedfoundation.org/awards/; as well as many exclusive networking and partnering opportunities.
RMF Executive Director Bernard Siegel, founder and co-chair of the Summit said, “We are proud to select Miami to be our host for the next World Stem Cell Summit. Miami is often referred to as the 'City of the Future' and in 2018 it will be the center of the stem cell universe. It’s the perfect venue for Summit attendees to gain knowledge, network and collect opportunities to advance their goals, in a superlative, cosmopolitan setting.”
ABOUT RMF Regenerative Medicine Foundation is dedicated to accelerating regenerative medicine to improve health and deliver cures. RMF pursues its mission by producing its flagship World Stem Cell Summit, honoring leaders through the Stem Cell Action Awards http://worldstemcellsummit.com/stem-cell-action-awards/, publishing the World Stem Cell Report and RegMed Newsletter, organizing educational initiatives such as the upcoming Regenerative Medicine Essentials Course http://www.wakehealth.edu/Research/WFIRM/RMEssentials/Regenerative-Medicine-Essentials.htm and fostering strategic collaborations.
For more information about RMF, visit www.regmedfoundation.org or contact Bernard Siegel directly at [email protected].
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/64ef8cd8-84a3-4130-8a8f-f1e020eaeba3
Bernard Siegel Regenerative Medicine Foundation 3058014928 [email protected]


SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans
GameStop Misses Q3 Revenue Estimates as Digital Shift Pressures Growth
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
Gulf Sovereign Funds Unite in Paramount–Skydance Bid for Warner Bros Discovery
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO
Westpac Director Peter Nash Avoids Major Investor Backlash Amid ASX Scrutiny
Air Transat Reaches Tentative Agreement With Pilots, Avoids Strike and Restores Normal Operations
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S.
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
ADB Approves $400 Million Loan to Boost Ease of Doing Business in the Philippines
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 



